Figure 6From: Potential of recombinant inorganic pyrophosphatase antigen as a new vaccine candidate against Baylisascaris schroederi in miceRPS rates in immunized mice. Mice were immunized three times with rBsc-PYP-1/FCA/PBS (O), FCA/PBS () or PBS (), followed by oral challenge with 3200 B. schroederi infective embryonated eggs at 2Â weeks after the last immunization in trial I. Each group consisted of 10 mice. All mice were monitored for mortality for 80Â days after the challenge, and the mortality rates (right side) corresponding to RPS rates (left side) are shown. Statistically significant differences (P < 0.05) are indicated by asterisks.Back to article page